Lawrence Flechner
Impact in
- Aging top 5%
- Transplantation top 5%
Papers in
-
- Renal Transplantation Outcomes and Treatments 2
-
- Cancer-related gene regulation 2
- PI3K/AKT/mTOR signaling in cancer 2
- Metabolism, Diabetes, and Cancer 2
- Genomics and Chromatin Dynamics 2
- Histone Deacetylase Inhibitors Research 2
- Co-authors
- Marc Montminy (5 shared papers)Xinmin Zhang (1 shared paper)Susan A. Hedrick (1 shared paper)Fayçal Boussouar (1 shared paper)Paul K. Brindle (1 shared paper)Wu Xu (1 shared paper)Seung‐Hoi Koo (1 shared paper)Ling Qi (1 shared paper)
- Journals
- Molecular and Cellular Biology (3 papers)The Journal of Urology (3 papers)PLoS ONE (2 papers)Molecular Cell (2 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Lawrence Flechner
18 papers receiving 1.8k citations
Lawrence Flechner's Hit Papers
Peers
Comparison fields: 5 of 122
- Aging 48
- Transplantation 47
- Molecular Biology 1.2k
- Endocrinology, Diabetes and Metabolism 228
- Geriatrics and Gerontology 46
Countries citing papers authored by Lawrence Flechner
This map shows the geographic impact of Lawrence Flechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Flechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Flechner more than expected).
Fields of papers citing papers by Lawrence Flechner
This network shows the impact of papers produced by Lawrence Flechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Flechner. The network helps show where Lawrence Flechner may publish in the future.
Co-authors
The 25 scholars most cited alongside Lawrence Flechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism Hit paper breakdown → | 2005 | 861 |
| 2 | 2003 | 216 | |
| 3 | 2004 | 182 | |
| 4 | 1999 | 101 | |
| 5 | 2015 | 74 | |
| 6 | 1998 | 74 | |
| 7 | 2011 | 68 | |
| 8 | 2006 | 66 | |
| 9 | 2010 | 53 | |
| 10 | 1999 | 49 | |
| 11 | 2012 | 36 | |
| 12 | 2012 | 29 | |
| 13 | Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth. | 2000 | 25 |
| 14 | 2011 | 20 | |
| 15 | 2018 | 11 | |
| 16 | 2003 | 10 | |
| 17 | 2006 | 8 | |
| 18 | 2012 | 2 | |
| 19 | 2014 | 0 |
About Lawrence Flechner
Lawrence Flechner is a scholar working on Transplantation, Molecular Biology, Urology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 19 papers that have together received 1.9k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (3 papers), Renal Transplantation Outcomes and Treatments (2 papers), Cancer-related gene regulation (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Genomics and Chromatin Dynamics (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Urological Disorders and Treatments (2 papers). The work is most often cited by research in Aging (48 citations), Transplantation (47 citations), Molecular Biology (1.2k citations), Endocrinology, Diabetes and Metabolism (228 citations) and Geriatrics and Gerontology (46 citations). Lawrence Flechner has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Marc Montminy, Xinmin Zhang, Susan A. Hedrick, Fayçal Boussouar, Paul K. Brindle, Wu Xu, Seung‐Hoi Koo, Ling Qi, Hiroshi Takemori and Robert A. Screaton. Their work appears in journals such as Molecular and Cellular Biology, The Journal of Urology, PLoS ONE, Molecular Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.